Our Research

1.      Clinical trials

Current

• SURPASS-CVOT: Principal Investigator (multicentre international study) -The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes
• DFUT study: Principal Investigator -Clinical and Economic Impact of Telemedicine in Management of Diabetes-Related Foot Ulceration in Rural/Remote areas of North Queensland: A Pilot Study
• Increased awareness of and access to diabetes and tuberculosis care in New Ireland Province of Papua New Guinea

Completed

• GIED study: examining the role of vildagliptin on IL-6 regulation in diabetic patients with foot ulcers
• TECOS – Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
• LEADER - Principal investigator - Liraglutide in patients with type 2 diabetes with cardiovascular disease
• AT. Lantus - Principal investigator - Comparing insulin regimens in complicated type 2 diabetes clients
• ELIXA: Evaluation of lixisinatide in acute coronary syndrome
• LANDSCAPE: Comparison of insulin Glargine/Glulisine with mixed insulin
• The role of oxidised lipids in atheroma formation and metabolic syndrome
• Understanding macrophage biology associated with atherogenesis
• Novel markers for identifying cardiovascular risk factors
• Invitro studies in understanding mechanisms in inflammation associated with diabetic foot ulcers.
• To improve the efficiency and effectiveness of care for persons with diabetes living in rural/remote areas through improved clinical triage, workflow, and intervention using information and alerts from telemonitoring e-devices
• To improve clinical outcomes and satisfaction of patients enrolled in the program

2.      Basic science research:

3.      Townsville TeleDiabetes and TeleEndocrinology Network -objectives

Overall, research at the TREAD is directed towards improved understanding and novel treatments for diabetic foot ulcers and metabolic syndrome.